Sign inGet started

ORLOFF JOHN J

Insider CIK 1643941 · BXLT See Remarks · ZBIO Director · NVLN See Remarks, Director · ALXN EVP, Research & Development

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZBIO Zenas BioPharma, Inc. A Award deriv2026-06-152026-06-1718,500— $018,500SEC↗
ZBIO Zenas BioPharma, Inc. A Award deriv2025-06-102025-06-1218,500— $018,500SEC↗
ZBIO Zenas BioPharma, Inc. A Award deriv2024-09-122024-09-1618,500— $018,500SEC↗
ALXN ALEXION PHARMACEUTICALS, I D To issuer2021-07-212021-07-23146,511— $00SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2021-07-142021-07-1630,643— $0117,010SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2021-07-142021-07-1629,501— $0146,511SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2021-06-082021-06-091,957$177.00 $346.4K86,367SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2021-02-282021-03-0224,473— $088,324SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2020-12-162020-12-1840,677— $085,206SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2020-12-162020-12-1818,134$157.96 $2.86M67,072SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2020-12-162020-12-183,261$157.96 $515.1K63,811SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2020-12-152020-12-1840$93.53 $3.7K63,851SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2020-06-082020-06-092,784$114.61 $319.1K44,529SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2020-03-022020-03-031,396$90.54 $126.4K47,275SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2020-02-282020-03-0310,880— $048,671SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2019-12-152020-03-0338$93.86 $3.6K47,313SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2019-06-072019-06-112,786$118.61 $330.4K37,791SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2019-02-282019-03-04675$132.92 $89.7K31,115SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2019-02-282019-03-059,428— $040,577SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2018-12-152019-03-0434$93.01 $3.2K31,149SEC↗
NVLN NOVELION THERAPEUTICS INC. A Award deriv2018-08-092018-08-1310,000— $010,000SEC↗
ALXN ALEXION PHARMACEUTICALS IN S Sale2018-06-082018-06-122,115$118.53 $250.7K31,790SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2018-02-282018-03-028,940— $033,905SEC↗
NVLN NOVELION THERAPEUTICS INC. A Award deriv2017-07-032017-07-059,600— $09,600SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2017-06-072017-06-0924,965— $024,965SEC↗
NVLN NOVELION THERAPEUTICS INC. A Award deriv2016-12-222016-12-27166,020— $0166,020SEC↗
BXLT Baxalta Inc D To issuer deriv2016-06-032016-06-0721,667— $00SEC↗
BXLT Baxalta Inc D To issuer deriv2016-06-032016-06-0782,063— $00SEC↗
BXLT Baxalta Inc D To issuer deriv2016-06-032016-06-0788,168— $00SEC↗
BXLT Baxalta Inc D To issuer2016-06-032016-06-0796,384— $00SEC↗
BXLT Baxalta Inc F Tax w/h2016-03-032016-03-071,408$39.30 $55.3K96,009SEC↗
BXLT Baxalta Inc A Award2016-03-032016-03-0755,951— $097,417SEC↗
BXLT Baxalta Inc J Other deriv2015-07-012015-07-0688,168— $088,168SEC↗
BXLT Baxalta Inc A Award deriv2015-07-012015-07-0682,063— $082,063SEC↗
BXLT Baxalta Inc J Other deriv2015-07-012015-07-0621,667— $021,667SEC↗
BXLT Baxalta Inc J Other2015-07-012015-07-0640,521— $040,521SEC↗